PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) today announced that its executive staff will be meeting with
analysts and investors at the American Society for Radiation
Oncology (ASTRO) Annual Meeting in Chicago on Monday,
September 16, 2019 at 2:00 p.m.
Central Time.
Information about the webcast of the company's presentation will
be available through a link on the company website at
www.varian.com/investors.
To attend Varian's ASTRO investor meeting, please RSVP to
Katie Glenn at
katie.glenn@varian.com by August 23,
2019.
For automatic e-mail alerts regarding Varian news and events,
investors can subscribe on the company website:
http://investors.varian.com/emailalerts.
About Varian
At Varian, we envision a world without fear of cancer. For
more than 70 years, we have developed, built and delivered
innovative cancer care technologies and solutions for our clinical
partners around the globe to help them treat millions of patients
each year. With an Intelligent Cancer Care approach, we are
harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries
keep the patient and our clinical partners at the center of our
thinking as we power new victories in cancer care. Because, for
cancer patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
Forward-Looking
Statements
Except for historical
information, this news release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Statements concerning the expected impact of proposed
tariffs or other financial results; and any statements using the
terms "could," "believe," "expect," "promising," "outlook,"
"should," "well-positioned," "will" or similar statements are
forward-looking statements that involve risks and uncertainties
that could cause the company's actual results to differ materially
from those anticipated. Such risks and uncertainties include the
final terms of any new tariffs and whether any reciprocal tariffs
are imposed, our ability to achieve expected synergies from
acquisitions; risks associated with integrating recent
acquisitions; global economic conditions and changes to trends for
cancer treatment regionally; currency exchange rates and tax rates;
the impact of the Tax Cuts and Jobs Act; the impact of the
Affordable Health Care for America Act (including excise taxes on
medical devices) and any further healthcare reforms (including
changes to Medicare and Medicaid), and/or changes in third-party
reimbursement levels; recent and potential future tariffs or a
global trade war; demand for and delays in delivery of the
company's products; the company's ability to develop, commercialize
and deploy new products; the company's ability to meet Food and
Drug Administration (FDA) and other regulatory requirements,
regulations or procedures; changes in regulatory environments;
risks associated with the company providing financing for the
construction and start-up operations of particle therapy centers,
challenges associated with commercializing the company's proton
solutions business; challenges to public tender awards and the loss
of such awards or other orders; the effect of adverse publicity;
the company's reliance on sole or limited-source suppliers; the
company's ability to maintain or increase margins; the impact of
competitive products and pricing; the potential loss of key
distributors or key personnel; challenges related to entering into
new business lines; and the other risks listed from time to time in
the company's filings with the Securities and Exchange Commission,
which by this reference are incorporated herein. The company
assumes no obligation to update or revise the forward-looking
statements in this release because of new information, future
events, or otherwise.
|
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-to-host-investor-meeting-at-astro-in-chicago-300898461.html
SOURCE Varian